BLOG

Whole Health Series:
Mental Health & Breast Care

Maimah Karmo shares how embracing mental health is key to true healing.

Whole Health Series:
Guide for Fertility & Preservation

Maimah Karmo shares her story of fertility and hope after cancer.

Whole Health Series:
Navigating the Stages of Healing in Survivorship

Survivorship isn’t the end of the story—it’s the beginning of a new one.

Study Sponsor: Seagen

This trial studies how well the drug tucatinib works when given with trastuzumab deruxtecan. It will also look at what side effects happen when these drugs are given together. A side effect is anything a drug does besides treating cancer. Participants in this trial have HER2-positive (HER2+) breast cancer that has either spread to other parts of the body (metastatic) or cannot be removed completely with surgery (unresectable). All participants will get both tucatinib and trastuzumab deruxtecan.

Study Sponsor: Sanofi

This study looks at how safe and effective the study drug, atezolizumab, is when given with paclitaxel. To do this, they are comparing the treatment regimen with and without the study medication.

Study Sponsor: Genentech/Hoffmann-La Roche

This study looks at how safe and effective the study drug, atezolizumab, is when given with paclitaxel. To do this, they are comparing the treatment regimen with and without the study medication.

Study Sponsor: Bristol-Myers Squibb

This study is evaluating the efficacy and safety of nivolumab compared to placebo when given with neoadjuvant (pre-surgery) chemotherapy and adjuvant (post-surgery) endocrine therapy in participants with high-risk, estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+, HER2-) early-stage breast cancer.

Lisa Lakey Interview (Part 2)

For many, there comes a de?ning moment in our lives that shapes who we are and who we will become. These moments, often arising unexpectedly, force us to discover deeper parts of ourselves that we had no idea laid dormant underneath the identities that we’d spent decades creating and curating.

Sam McKinnon Interview (Part 2)

Though now cancer-free, Sam McKinnon, 32, still struggles with infections and other health-related issues. This is common among many cancer survivors, despite it often not being widely known among those who have not personally battled or known someone else who has battled cancer.